$VXRT Vaxart expects to announce results from its collaboration with $JNJ Johnson &amp; Johnson on a universal influenza vaccine soon. It also hopes to begin a phase 1 clinical study of its oral COVID-19 vaccine in the second half of 2020.  #LONG #CovidVaccine #Biotech #Biotechnology